title: An adverse outcome pathway framework for neural tube and axial defects mediated by modulation of retinoic acid homeostasis.
abstract: Developmental toxicity can be caused through a multitude of mechanisms and can therefore not be captured through a single simple mechanistic paradigm. However, it may be possible to define a selected group of overarching mechanisms that might allow detection of the vast majority of developmental toxicants. Against this background, we have explored the usefulness of retinoic acid mediated regulation of neural tube and axial patterning as a general mechanism that, when perturbed, may result in manifestations of developmental toxicity that may cover a large part of malformations known to occur in experimental animals and in man. Through a literature survey, we have identified key genes in the regulation of retinoic acid homeostasis, as well as marker genes of neural tube and axial patterning, that may be used to detect developmental toxicants in in vitro systems. A retinoic acid-neural tube/axial patterning adverse outcome pathway (RA-NTA AOP) framework was designed. The framework was tested against existing data of flusilazole exposure in the rat whole embryo culture, the zebrafish embryotoxicity test, and the embryonic stem cell test. Flusilazole is known to interact with retinoic acid homeostasis, and induced common and unique NTA marker gene changes in the three test systems. Flusilazole-induced changes were similar in directionality to gene expression responses after retinoic acid exposure. It is suggested that the RA-NTA framework may provide a general tool to define mechanistic pathways and biomarkers of developmental toxicity that may be used in alternative in vitro assays for the detection of embryotoxic compounds.
authors.affiliation: Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands.
authors.forename: Elisa C M
authors.initials: EC
authors.lastname: Tonk
authors.affiliation: Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands.
authors.forename: Jeroen L A
authors.initials: JL
authors.lastname: Pennings
authors.affiliation: Center for Health Protection, National Institute for Public Health and The Environment (RIVM), P.O. Box 1, 3720BA Bilthoven, The Netherlands; Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: aldert.piersma@rivm.nl.
authors.forename: Aldert H
authors.initials: AH
authors.lastname: Piersma
mesh_terms: D000818:Animals; D019521:Body Patterning / Q000187:drug effects*; D004625:Embryo, Nonmammalian / Q000187:drug effects; D053595:Embryonic Stem Cells / Q000187:drug effects; D006706:Homeostasis; D054259:Neural Tube / Q000187:drug effects*; D051381:Rats; D012821:Silanes / Q000633:toxicity; D013723:Teratogens / Q000633:toxicity*; D014212:Tretinoin / Q000378:metabolism*; D014230:Triazoles / Q000633:toxicity; D015027:Zebrafish
chemical_list: D012821:Silanes; D013723:Teratogens; D014230:Triazoles; D014212:Tretinoin; C061365:flusilazole
keywords: Axial patterning; Biomarkers; Developmental toxicity; Embryogenesis; Gene expression; Malformations; Neural tube patterning; Retinoic acid